Obstructive Sleep Apnea: Symptoms, Diagnosis, and Treatment — What Your Doctor Wants You to Know in 2026
Written by Dr. Kathryn Kline, MD, Board-Certified Family Medicine Physician | Medically reviewed by Dr. Casey Dean, DO | Trinity Family Medicine
Last medically reviewed: July 2026
Obstructive sleep apnea is the most common serious medical condition that most people who have it don't know they have. Depending on the criteria researchers use, somewhere between 30 million and 80 million American adults have obstructive sleep apnea — and across every published estimate, roughly 80% have never been diagnosed. They stop breathing dozens or hundreds of times a night, with no idea it's happening.
Here is what makes obstructive sleep apnea (OSA) so easy to miss: almost nobody walks into a doctor's office and says, "I think I have sleep apnea." They come in for something else. Blood pressure that won't come down. Exhaustion that sleep doesn't fix. Weight that won't move. Brain fog that looks like burnout. OSA hides behind another complaint — and if nobody asks the right questions, it stays hidden.
Quick Summary: Key Facts at a Glance
What it is & its classic symptom: Obstructive sleep apnea is the repeated collapse of the upper airway during sleep. Breathing stops (apnea) or becomes shallow (hypopnea) for 10 seconds or longer, dropping your blood oxygen and jolting your body awake. The hallmark sign is loud, habitual snoring broken by silent pauses, gasping, or choking — usually noticed by a bed partner — plus waking unrefreshed. It is not simply "bad snoring."
Primary risk factors: Excess weight, male sex, age over 40, a large neck, family history, and menopause in women. But a 2025 analysis of 12,860 adults found that most adults with OSA do not have obesity: 23.5% were normal weight or underweight, and 44.4% were overweight. A normal BMI does not rule it out.
How it's diagnosed: OSA cannot be diagnosed from symptoms or a questionnaire alone. The American Academy of Sleep Medicine requires either an in-lab sleep study (polysomnography) or a home sleep apnea test. Both measure the apnea-hypopnea index (AHI) — breathing events per hour. An AHI of 5–14 is mild, 15–30 is moderate, and above 30 is severe.
First-line treatment: CPAP (continuous positive airway pressure) — a mask that blows a gentle stream of air to hold your airway open — remains the most effective treatment for moderate-to-severe OSA. Alternatives include oral appliances, weight loss, positional therapy, hypoglossal nerve stimulation (an implanted device that keeps your tongue from blocking the airway), and — since December 2024 — tirzepatide (Zepbound), the first medication ever FDA-approved for OSA.
When to see a doctor: Any witnessed pauses in breathing, unrefreshing sleep with daytime sleepiness, or blood pressure that stays high on three or more medications deserves an evaluation. A telehealth visit can assess your symptoms, figure out how likely OSA is for you, and arrange testing.
Emergency red flags: Falling asleep while driving, waking with gasping and chest pain, or new morning confusion — seek urgent care. Drowsy driving is a medical emergency waiting to happen.
What Obstructive Sleep Apnea Actually Does to Your Body
When you fall asleep, the muscles holding your throat open relax. In people with OSA, the airway narrows and then collapses entirely. Air stops moving. Your blood oxygen falls.
Your brain, sensing suffocation, fires an alarm. It floods your body with adrenaline, spikes your heart rate and blood pressure, and briefly wakes you just enough to reopen the airway — usually with a gasp. You take a few breaths, fall back asleep, and the cycle starts over. Now repeat that 30, 60, or 100 times an hour, all night, for years.
You almost never remember these awakenings. What you experience is simply that sleep isn't working. But your cardiovascular system remembers all of it. Those nightly surges of adrenaline and oxygen deprivation are why OSA is an independent risk factor for high blood pressure, atrial fibrillation, coronary artery disease, heart failure, and stroke — meaning it raises your risk on its own, even after accounting for weight, smoking, cholesterol, and diabetes.
This is the part most people miss. Sleep apnea is not a sleep problem that happens to affect your heart. It is a cardiovascular and metabolic disease that happens to occur during sleep.
The Four Doors: How Sleep Apnea Walks Into Primary Care
In family medicine, OSA almost never announces itself. It arrives disguised as something else. These are the four presentations that should always prompt a sleep apnea conversation — and the ones most often missed.
Door 1: Blood Pressure That Won't Budge
This is the most important and most overlooked connection in primary care. Obstructive sleep apnea is the most common identifiable secondary contributor to resistant hypertension — blood pressure that stays above goal despite three or more medications. Studies find OSA in roughly 25–50% of patients with resistant hypertension.
The 2025 AHA/ACC hypertension guideline specifically recommends screening for OSA in patients with resistant hypertension who also have snoring, witnessed breathing pauses, or daytime sleepiness. If you are on three blood pressure medications and your numbers still aren't controlled, a sleep study may do more for you than a fourth pill.
Door 2: Fatigue and Brain Fog That Look Like Depression or ADHD
Fragmented sleep produces exactly the symptoms most people associate with mental health conditions: low energy, irritability, poor concentration, and memory lapses. It is entirely possible to be treated for depression or evaluated for adult ADHD when the real driver is an airway collapsing 40 times an hour.
This matters especially for women, who are far less likely to show the "classic" picture of loud snoring and daytime sleepiness. They more often report fatigue, insomnia, morning headaches, and mood changes — symptoms that get blamed on stress, depression, anxiety, or perimenopause. The stereotype that sleep apnea is an overweight middle-aged man's disease is a major reason women go undiagnosed for years.
Worth knowing: Depression that isn't responding to treatment should always prompt at least one question about snoring and witnessed breathing pauses.
Door 3: Weight That Won't Move
The relationship between weight and OSA runs both ways. Excess weight — especially around the neck and abdomen — narrows the airway and makes collapse more likely. But OSA also makes weight loss harder. Fragmented sleep raises cortisol (your main stress hormone), worsens insulin resistance (how well your body handles blood sugar), increases ghrelin (a hunger hormone), and leaves you too exhausted to exercise. People who plateau despite real effort are sometimes fighting an untreated sleep disorder they don't know about.
Door 4: Low Testosterone in Men
Testosterone is produced mostly during deep, uninterrupted sleep, so when sleep is shattered hundreds of times a night, testosterone production suffers.
This one has a sting in the tail. Men are sometimes started on testosterone replacement for fatigue and low libido when untreated OSA is the real driver — and the Endocrine Society specifically recommends against testosterone therapy in men with untreated severe obstructive sleep apnea, because it may worsen the condition. Any evaluation for low testosterone should include a sleep history first.
How Sleep Apnea Is Diagnosed
Here is a point worth stating plainly, because a lot of online health content gets it wrong: you cannot diagnose obstructive sleep apnea from symptoms, a questionnaire, a smartwatch, or a snoring app. The American Academy of Sleep Medicine is explicit that questionnaires and prediction tools should not be used to diagnose OSA in place of an actual sleep study.
What questionnaires are good for is deciding who needs testing. The most widely used is STOP-BANG — eight yes/no questions covering Snoring, Tiredness, Observed apneas, high blood Pressure, BMI, Age, Neck circumference, and Gender. A score of 3 or higher signals increased risk and should trigger testing. It's a sensitive net, not a diagnosis.
Diagnosis requires one of two tests:
| Test | What it is | Best for |
|---|---|---|
| Home sleep apnea test (HSAT) | A small portable device you wear at home overnight. It measures airflow, breathing effort, oxygen levels, and heart rate. | Otherwise-healthy adults whose symptoms suggest moderate-to-severe OSA |
| In-lab polysomnography (PSG) | A full overnight study in a sleep lab, with more complete monitoring including brain waves. | Patients with significant heart or lung disease, muscle weakness, chronic opioid use, prior stroke, or severe insomnia — and anyone whose home test was negative or unclear |
That last point matters: a negative home sleep apnea test does not rule out sleep apnea. If your symptoms are convincing and your home test comes back clean, AASM guidelines say the next step is a full in-lab study — not reassurance.
Both tests produce your AHI (apnea-hypopnea index): the average number of times per hour your breathing stopped or became dangerously shallow. Five to 14 events per hour is mild, 15 to 30 is moderate, and more than 30 is severe.
What If You Feel Fine?
In November 2022, the U.S. Preventive Services Task Force concluded there is insufficient evidence to recommend for or against screening adults who have no symptoms at all.
This gets misread constantly as "screening doesn't work." It means only that the evidence in genuinely symptom-free adults isn't strong enough for a population-wide recommendation. It has no bearing on you if you have symptoms. In that case you aren't being screened — you're being evaluated, and that is clearly indicated.
Treatment: What Actually Works in 2026
CPAP Remains the Gold Standard
Continuous positive airway pressure delivers a steady stream of air through a mask, acting like an air splint that holds your airway open. For moderate-to-severe OSA, nothing else matches it. Modern machines are quiet, and today's small nasal-pillow masks look nothing like the equipment most people picture.
CPAP's limitation has never been whether it works. It's whether people keep using it. If you tried CPAP and abandoned it, that's worth revisiting — mask refitting, added humidification, and pressure adjustments solve a large share of the problems that make people quit.
Oral Appliances
A custom-fitted dental device moves the lower jaw forward to keep the airway open. It's a legitimate option for mild-to-moderate OSA, and for people with severe disease who truly cannot tolerate CPAP. These devices are less effective at high AHI levels and can shift your teeth over time.
Weight Loss — and the First-Ever OSA Medication
On December 20, 2024, the FDA approved Zepbound (tirzepatide) for moderate-to-severe obstructive sleep apnea in adults with obesity — the first medication ever approved to treat OSA. The approval rested on two randomized, placebo-controlled trials of 469 adults without type 2 diabetes: one group already using PAP therapy, one group unable or unwilling to use it. Participants received 10 or 15 mg of tirzepatide or placebo weekly for 52 weeks. Both groups saw significant reductions in AHI compared with placebo, and more participants reached remission or mild OSA with symptoms resolved.
Two caveats matter. It is approved specifically for adults with obesity, used alongside a reduced-calorie diet and more physical activity — not as a standalone therapy for everyone with OSA. And the FDA noted the AHI improvement is likely driven by the weight loss itself. This is a real advance, not a replacement for CPAP in most patients. (Our GLP-1 weight-loss program covers both tirzepatide and semaglutide.)
Positional Therapy, Surgery — and What Doesn't Help
Some people have OSA almost exclusively when sleeping on their back, and devices that keep you on your side can help. For selected patients who can't tolerate CPAP, hypoglossal nerve stimulation — an implanted device (such as Inspire) that stimulates the nerve controlling tongue position — is FDA-approved and effective.
What won't fix it: alcohol before bed, sedatives, and untreated nasal congestion all worsen airway collapse. And while good sleep timing genuinely matters, no amount of sleep hygiene will hold open an airway that is collapsing mechanically. Sleep apnea is a plumbing problem, not a scheduling problem.
When to See Your Doctor
Book an evaluation if any of these apply to you:
Someone has seen you stop breathing, gasp, or choke during sleep
You snore loudly and habitually, and wake up unrefreshed
You feel sleepy during the day despite enough time in bed
You wake with morning headaches or a dry mouth
Your blood pressure stays high despite three or more medications
You've been treated for depression or fatigue without improvement
Seek urgent care immediately if you have fallen asleep — or nearly fallen asleep — while driving. Untreated OSA substantially raises crash risk, and this is not something to wait on.
Much of a sleep apnea evaluation happens through conversation, which translates well to telehealth. Trinity Family Medicine offers physician-led telehealth visits across Texas starting at $49.99, and you see the same doctor every visit.
In a video appointment, your physician can take a detailed sleep history, score you on STOP-BANG, arrange the right sleep test, and treat the problems OSA drives — blood pressure, weight, testosterone, and mood. Book at trinitymedtx.com/book or call 817-932-4022.
One note for Texans: our cedar and oak allergy seasons drive months of nasal congestion, and a blocked nose both worsens airway collapse and makes CPAP harder to tolerate. Treating the nose is an underrated part of treating the airway.
Frequently Asked Questions
Can you have sleep apnea without snoring?
Yes. Snoring is common in obstructive sleep apnea but is not required for the diagnosis. This is especially true for women, who more often present with fatigue, insomnia, morning headaches, and mood changes rather than loud snoring — a major reason sleep apnea is underdiagnosed in women.
Can you have sleep apnea if you are not overweight?
Yes — more often than most people assume. A 2025 analysis pooling data on 12,860 adults from four community studies found that most adults with OSA do not have obesity: 23.5% were normal weight or underweight, and 44.4% were overweight. Airway anatomy — a narrow jaw, large tonsils, or a recessed chin — can cause airway collapse regardless of body weight.
Does a smartwatch or phone app diagnose sleep apnea?
No. Wearables may detect snoring, oxygen dips, or irregular breathing, and can be a useful nudge to get evaluated — but they cannot diagnose obstructive sleep apnea. A formal diagnosis requires a home sleep apnea test or in-lab polysomnography measuring your apnea-hypopnea index.
Is Zepbound (tirzepatide) a replacement for CPAP?
Not for most patients. Zepbound was FDA-approved in December 2024 for moderate-to-severe OSA specifically in adults with obesity, used alongside a reduced-calorie diet and increased physical activity. CPAP remains the most effective treatment, and whether to use tirzepatide instead of — or in addition to — PAP therapy is a decision to make with your physician.
What happens if sleep apnea goes untreated?
Untreated obstructive sleep apnea is an independent risk factor for high blood pressure, atrial fibrillation, coronary artery disease, heart failure, and stroke, and it worsens insulin resistance and type 2 diabetes. It also substantially raises the risk of motor vehicle crashes from daytime sleepiness.
The Bottom Line
Obstructive sleep apnea is common, dangerous, highly treatable, and — in roughly 80% of the people who have it — completely undiagnosed. It rarely shows up as a sleep complaint. Far more often it appears as blood pressure that won't come down, fatigue mistaken for depression, weight that won't move, or low testosterone. If you snore and wake unrefreshed, or if someone has watched you stop breathing at night, that is not a quirk to live with. It is a treatable medical condition — and the evaluation starts with a single conversation.
References
U.S. Food and Drug Administration. "FDA Approves First Medication for Obstructive Sleep Apnea." FDA News Release, 2024 fda.gov/news-events/press-announcements/fda-approves-first-medication-obstructive-sleep-apnea
U.S. Preventive Services Task Force. "Obstructive Sleep Apnea in Adults: Screening." USPSTF Final Recommendation Statement, 2022 uspreventiveservicestaskforce.org/uspstf/recommendation/obstructive-sleep-apnea-in-adults-screening
Kapur VK, Auckley DH, Chowdhuri S, et al. "Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline." Journal of Clinical Sleep Medicine, 2017 pmc.ncbi.nlm.nih.gov/articles/PMC5337595/
Yeghiazarians Y, Jneid H, Tietjens JR, et al. "Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association." Circulation, 2021;144(3):e56–e67 ahajournals.org/doi/10.1161/CIR.0000000000000988
American Heart Association / American College of Cardiology. "2025 AHA/ACC Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults." Circulation, 2025 ahajournals.org/doi/10.1161/CIR.0000000000001356
"The relationship between obesity and obstructive sleep apnea in four community-based cohorts: an individual participant data meta-analysis of 12,860 adults." eClinicalMedicine (The Lancet), 2025 thelancet.com/journals/eclinm/article/PIIS2589-5370(25)00153-1/fulltext
Bhasin S, Brito JP, Cunningham GR, et al. "Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline." The Journal of Clinical Endocrinology & Metabolism, 2018;103(5):1715–1744 academic.oup.com/jcem/article/103/5/1715/4939465
Nagappa M, Liao P, Wong J, et al. "Validation of the STOP-Bang Questionnaire as a Screening Tool for Obstructive Sleep Apnea among Different Populations: A Systematic Review and Meta-Analysis." PLoS ONE, 2015 ncbi.nlm.nih.gov/pmc/articles/PMC4678295/
American Academy of Sleep Medicine. "Zepbound approved by FDA as first sleep apnea medication." AASM, 2024 aasm.org/zepbound-approved-fda-first-sleep-apnea-medication/
About the Author
Board-Certified Family Medicine Physician (ABFM)
Dr. Kathryn Kline is a board-certified family medicine physician and co-founder of Trinity Family Medicine. She is dedicated to mental and emotional wellness, women's health, and chronic disease management, serving patients across Texas via secure telehealth.
Credentials & Memberships:
- Doctor of Medicine (MD) — University of Cincinnati Medical Center
- Family Medicine Residency — Waco Family Medicine (Nationally Ranked)
- Board Certified — American Board of Family Medicine (ABFM)
- Texas Medical Board License: #T3117
- Specialty: Mental Health, Women's Health, Chronic Disease Management
Medical Review Date: July 2026, by Dr. Casey Dean, DO, Texas Medical Board License T3065
Standard Texas Telehealth Medical Disclaimer
Medical Disclaimer: The information provided in this article is for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified healthcare provider with any questions you may have regarding a medical condition.
Emergency Notice: If you are experiencing a medical emergency, please call 911 or go to the nearest emergency room immediately. A virtual consultation is not a substitute for emergency medical care.
Texas Patient Notice: Use of this website or the information contained herein does not establish a doctor-patient relationship. A formal relationship is only established after a synchronous video consultation with a Texas-licensed provider and the completion of all required intake documentation.
Ready to Feel Better?
Connect with a Texas-licensed physician today — no waiting rooms, no hassle.
Book Your ConsultationReady to Get Started in Texas?
Explore the physician-led services discussed in this article.
Related Articles
Vitamin B12 Deficiency: Symptoms, Causes, and Treatment — What Your Doctor Wants You to Know in 2026
Vitamin B12 deficiency affects roughly 2–3% of U.S. adults and is one of the most fixable causes of fatigue and nerve symptoms — but a "normal" lab doesn't always mean you're in the clear. Here's what to watch for, why metformin and acid reducers matter, and how it's treated in 2026.
Read moreHow Much Does a Doctor Visit Cost in Texas Without Insurance? (2026 Price Guide)
The same sinus infection costs $49.99 by video, about $200 at urgent care, and $2,000 at a freestanding ER. Two Texas physicians publish the real 2026 cash-price menu for uninsured Texans.
Read moreFatty Liver Disease (MASLD): Symptoms, the New 2026 Treatments, and How to Check Your Liver From Home
Fatty liver disease (MASLD) affects ~40% of U.S. adults and is usually silent. Dr. Casey Dean explains the FIB-4 score, lifestyle targets, and the new FDA-approved drugs for MASH.
Read more